A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...
Shares of Biogen Inc. BIIB slid 1.10% to $142.34 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback